Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

未开盘 11-04 16:00:00 EST

1,247.35

+0.61

+0.05%

High1,260.59	Low1,244.57	Vol33.15M
Open1,246.69	D1 Closing1,246.74	Amplitude1.29%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O717.44M	T/O Rate--	Tradable Shares0.00
P/B3.154308	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1247.3478,"timestamp":1730753999999,"preClose":1246.7402,"halted":0,"volume":33148130,"delay":0,"changeRate":0.000487,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":0.607544,"latestTime":"11-04 16:00:00 EST","open":1246.6887,"high":1260.5925,"low":1244.5657,"amount":717438287.517662,"amplitude":0.012855,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730817000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.154308,"peRate":533.111956,"turnoverRate":0.011192,"increases":4,"decrements":8,"flats":2,"marketCap":144027944115,"floatMarketCap":143330701918.75},"requestUrl":"/m/hq/s/BK4583/wiki","defaultTab":"wiki","newsList":[{"id":"2481506286","title":"T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481506286","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481506286?lang=en_us&edition=fundamental","pubTime":"2024-11-05 21:00","pubTimestamp":1730811600,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., Nov.  05, 2024  (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO),a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today tha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/05/2974863/32489/en/T2-Biosystems-to-Report-Third-Quarter-2024-Financial-Results-and-Business-Updates-on-November-14-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","TTOO","BK4139"],"gpt_icon":0},{"id":"2481059485","title":"Tonix Pharma Partners for Vaccine Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2481059485","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481059485?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:55","pubTimestamp":1730811307,"startTime":"0","endTime":"0","summary":"An update from Tonix Pharma  is now available.Tonix Pharmaceuticals has partnered with the Kenya Medical Research Institute to launch a Phase I clinical trial for its TNX-801 vaccine aimed at preventing mpox and smallpox. This collaboration will see Tonix sponsoring the trial while KEMRI leads its execution, marking a significant step in vaccine development and regulatory approval processes. Investors should note that this announcement includes forward-looking statements about the company’s future operations and market potential.Learn more about TNXP stock on TipRanks’ Stock Analysis page.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VaKCXGYM.Q2xBRfnsYVuuQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VaKCXGYM.Q2xBRfnsYVuuQ--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/4228d494699edc69b7f529ca87ad9ce2"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/tonix-pharma-partners-vaccine-clinical-125507147.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tonix-pharma-partners-vaccine-clinical-125507147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TNXP","BK4583","BK4139"],"gpt_icon":0},{"id":"2481650392","title":"Viatris Announces Third Quarter 2024 Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2481650392","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481650392?lang=en_us&edition=fundamental","pubTime":"2024-11-05 19:59","pubTimestamp":1730807940,"startTime":"0","endTime":"0","summary":"PITTSBURGH, Nov. 5, 2024 /PRNewswire/ -- Viatris Inc.  today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on December 13, 2024, to shareholders of record as of the close of business on November 22, 2024.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/usDQRM21dyb2WvynKfd45Q--~B/aD0xMTI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c03b6c5b724244b6bb2d566254fd974b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/usDQRM21dyb2WvynKfd45Q--~B/aD0xMTI7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c03b6c5b724244b6bb2d566254fd974b"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/viatris-announces-third-quarter-2024-115900234.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viatris-announces-third-quarter-2024-115900234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1839511570.USD","VTRS","LU2087621335.USD","BK4007","BK4583","BK4588","BK4585"],"gpt_icon":1},{"id":"2481486545","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Equillium (EQ), Quest Diagnostics (DGX) and Alnylam Pharma (ALNY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481486545","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481486545?lang=en_us&edition=fundamental","pubTime":"2024-11-05 14:21","pubTimestamp":1730787664,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Equillium (EQ – Research Report), Quest Diagnostic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-equillium-eq-quest-diagnostics-dgx-and-alnylam-pharma-alny?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-equillium-eq-quest-diagnostics-dgx-and-alnylam-pharma-alny?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4588","LU1854103824.USD","BK4548","LU1854104046.USD","DGX","BK4583","BK4139","HCSG","ALNY","EQ","BK4137","BK4196","BK4567","BK4585"],"gpt_icon":0},{"id":"2481956159","title":"Is Gilead Sciences, Inc. (GILD) the Best Pharma Stock to Buy Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2481956159","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481956159?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:53","pubTimestamp":1730760813,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now.In this article, we are going to take a look at where Gilead Sciences, Inc.  stands against the other pharma stocks.Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of new treatments, and design, manufacture, and market diagnostic equipment and tests. Breakthroughs in medical technology, pharmaceuticals, and treatment methods have transformed patient outcomes, with pharmaceutical companies, in particular, attracting significant attention as the demand for rapid results has increased. A report from Grand View Research estimates that the global pharmaceutical manufacturing market was valued at around $516.48 billion in 2022 and is projected to grow at a compound annual growth rate  of 7.63% from 2023 to 2030.At first glance, the pharma industry might look like it’s thriving. But, like any indus","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Um4TNVexWZPbbD.VZSDvzw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Um4TNVexWZPbbD.VZSDvzw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/11c0338c5011aa20a9d44b77386b4a12"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-inc-gild-best-225333653.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","LU0889565916.HKD","CAGR","IE00BKVL7J92.USD","LU2468319806.SGD","PSQ","LU1066051498.USD","LU1571399168.USD","MNQmain","LU1839511570.USD","BK4585","IE00B19Z3B42.SGD","BK4568","GILD","BK4566","QID","BK4141","QLD","LU0348723411.USD","LU0289739699.SGD","LU1066053197.SGD","BK4588","LU2087621335.USD","SQQQ","LU0109394709.USD","BK4532","BK4583","LU0234570918.USD","IE00BMPRXQ63.HKD","LU1585245621.USD","NQmain","BK4578","LU0058720904.USD","BK4139","IE0002270589.USD","LU0320765992.SGD","TQQQ","IE00BMPRXR70.SGD","IE00BZ1G4Q59.USD","BK4159","BK4550","IE00BMPRXN33.USD","IE00BSNM7G36.USD","LU1430594728.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2480558747","title":"BRIEF-Tonix Pharmaceuticals And Kenya Medical Research Institute To Design, Plan And Seek Regulatory Approval For Phase I Clinical Study Of TNX-801 For Mpox In Kenya","url":"https://stock-news.laohu8.com/highlight/detail?id=2480558747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480558747?lang=en_us&edition=fundamental","pubTime":"2024-11-04 23:33","pubTimestamp":1730734407,"startTime":"0","endTime":"0","summary":"Nov 4  - Tonix Pharmaceuticals Holding Corp :   * TONIX PHARMACEUTICALS ANNOUNCES RESEARCH AGREEMENT WITH KENYA MEDICAL RESEARCH INSTITUTE  TO DESIGN, PLAN AND SEEK REGULATORY APPROVAL FOR A PHASE I CLINICAL STUDY OF TNX-801 FOR MPOX IN KENYA   * TONIX PHARMACEUTICALS HOLDING CORP - TO TEST TNX-801 VACCINE FOR MPOX IN KENYA   * TONIX PHARMACEUTICALS HOLDING CORP - TO SPONSOR, KEMRI TO LEAD CLINICAL TRIAL FOR TNX-801Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","TNXP"],"gpt_icon":1},{"id":"2480758774","title":"Unveiling Viatris (VTRS) Q3 Outlook: Wall Street Estimates for Key Metrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2480758774","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480758774?lang=en_us&edition=fundamental","pubTime":"2024-11-04 22:16","pubTimestamp":1730729766,"startTime":"0","endTime":"0","summary":"In its upcoming report, Viatris  is predicted by Wall Street analysts to post quarterly earnings of $0.68 per share, reflecting a decline of 12.8% compared to the same period last year. Revenues are forecasted to be $3.68 billion, representing a year-over-year decrease of 6.6%.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.Bearing this in mind, let's now explore the average estimates of specific Viatris metrics that are commonly monitored and projected","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/auhFPLcthJM50UYepXcODg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2f0d6efdd8740952a371c97ddea6e926","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/auhFPLcthJM50UYepXcODg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2f0d6efdd8740952a371c97ddea6e926"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/unveiling-viatris-vtrs-q3-outlook-141606885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","VTRS","LU1839511570.USD","LU2087621335.USD","BK4007","BK4583","BK4585"],"gpt_icon":0},{"id":"2480588199","title":"BRIEF-Emergent Biosolutions Appoints Dr. Simon Lowry As Chief Medical Officer And Head Of Research And Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2480588199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480588199?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:23","pubTimestamp":1730726609,"startTime":"0","endTime":"0","summary":"Nov 4 (Reuters) - Emergent BioSolutions Inc   :   * EMERGENT BIOSOLUTIONS APPOINTS DR. SIMON LOWRY AS CHIEF MEDICAL OFFICER AND HEAD OF RESEARCH AND DEVELOPMENTSource text:    Further company coverage:    (Reuters.Briefs@thomsonreuters.com)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"gpt_icon":0},{"id":"2480300074","title":"Jefferies Remains a Buy on Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2480300074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480300074?lang=en_us&edition=fundamental","pubTime":"2024-11-04 21:15","pubTimestamp":1730726145,"startTime":"0","endTime":"0","summary":"In a report released today, Michael Yee from Jefferies maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-gilead-sciences-gild-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-gilead-sciences-gild-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","IE00BZ1G4Q59.USD","BK4568","BK4139","BK4532","GILD","BK4566","LU0109394709.USD","BK4550","BK4578","LU1839511570.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","LU2087621335.USD","LU0889565916.HKD","BK4588","LU0289739699.SGD","LU1430594728.SGD","LU0320765992.SGD","IE0002270589.USD","BK4585","LU1066053197.SGD","LU1571399168.USD","IE00BKVL7J92.USD","LU1066051498.USD","LU0234570918.USD","BK4583","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2480892305","title":"Here's Why You Should Retain DGX Stock in Your Portfolio Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2480892305","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480892305?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:52","pubTimestamp":1730724720,"startTime":"0","endTime":"0","summary":"Quest Diagnostics Inc.’s DGX third-quarter revenue growth can be attributed to the strong momentum in its expanding portfolio of Advanced Services. The company strategically deploys AI and automation to improve its operational quality and efficiency. Its base business volume remains robust, which is highly encouraging. However, the mounting debt burden on DGX’s balance sheet could pose challenges for its operations.In the past year, this Zacks Rank #2  company’s shares have risen 12.7% compared with the industry’s 11.4% growth and the S&P 500 composite’s 20.5% increase.In the third quarter, the questhealth.com platform reported 40% growth in total revenues. Also, its repeat customer rate has grown to 30% from less than 10% two years ago, largely due to demand for comprehensive health, chronic disease and STI  testing.In the third quarter, the company completed the build-out of full end-to-end automation for its core routine tests at its Lenexa, KS,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-retain-dgx-stock-125200026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","IE0009354923.USD","PAHC","BK4588","BK4198","LU0205193047.USD","LU0205194284.USD","BK4567","BK4585","BK4583","LU1854103824.USD","LU1854104046.USD","LU0012050646.USD","HAE","IE00B64QTZ34.USD","LU2065732104.USD","BK4196","LU1169590202.USD","LU1169589451.USD","GMED","BK4082","DGX","LU0106261612.USD","IE00BLDYK493.USD"],"gpt_icon":0},{"id":"2480304004","title":"Emergent BioSolutions Appoints DR. Simon Lowry as Chief Medical Officer and Head of Research and Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2480304004","media":"THOMSON REUTERS","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480304004?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:30","pubTimestamp":1730723401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUA15YXJR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EBS","BK4583","BK4139"],"gpt_icon":0},{"id":"2480302363","title":"Press Release: Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2480302363","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480302363?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:30","pubTimestamp":1730723400,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development. -- Executive Management Team appointments contribute to Emergent's. transformation and beyond, including promotion of Jessica Perl to General. \"I am pleased to welcome Dr. Simon Lowry to Emergent, and am confident that under his leadership, we will continue to make a meaningful impact on our patients' lives,\" said Joe Papa, president and chief executive officer of Emergent. \"Dr. Lowry has deep, executive-level experience in the healthcare and pharmaceutical industry that will take Emergent's scientific and research program to the next level, a critical step in our multi-year plan to turnaround and transform the company.\". \"I am drawn to Emergent given its strong mission and 25-year history in public health with a portfolio of vital medicines that safeguard communities against serious threats around the world,\" said Dr. Lowry. \"Emergent has key capabilities to advance its scient","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"gpt_icon":0},{"id":"2480613304","title":"Tonix Pharmaceuticals announces research agreement with KEMRI","url":"https://stock-news.laohu8.com/highlight/detail?id=2480613304","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480613304?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:16","pubTimestamp":1730722592,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals (TNXP) announced that it has entered into a sponsored research agreement with the Kenya Medical Research Institute, KEMRI, to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tonix-pharmaceuticals-announces-research-agreement-with-kemri?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tonix-pharmaceuticals-announces-research-agreement-with-kemri?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TNXP","BK4583"],"gpt_icon":0},{"id":"2480301593","title":"Tonix Pharmaceuticals Holding Corp - to Sponsor, Kemri to Lead Clinical Trial for Tnx-801","url":"https://stock-news.laohu8.com/highlight/detail?id=2480301593","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480301593?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUA6CP68P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","TNXP","BK4139"],"gpt_icon":0},{"id":"2480301316","title":"Tonix Pharmaceuticals Holding Corp - to Test Tnx-801 Vaccine for Mpox in Kenya","url":"https://stock-news.laohu8.com/highlight/detail?id=2480301316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480301316?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUA6CP68P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4583","TNXP"],"gpt_icon":0},{"id":"2480301306","title":"Tonix Pharmaceuticals Announces Research Agreement With Kenya Medical Research Institute (Kemri) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of Tnx-801 for Mpox in Kenya","url":"https://stock-news.laohu8.com/highlight/detail?id=2480301306","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480301306?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nTUA6CP68P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TNXP","BK4583","BK4139"],"gpt_icon":0},{"id":"2480304810","title":"Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya","url":"https://stock-news.laohu8.com/highlight/detail?id=2480304810","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480304810?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:00","pubTimestamp":1730721600,"startTime":"0","endTime":"0","summary":"Proposed clinical study in Kenya intended to test the safety, tolerability, and immunogenicity of TNX-801, a vaccine being developed to prevent mpox (formerly called monkeypox) The World Health Organi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/04/2973898/28908/en/Tonix-Pharmaceuticals-Announces-Research-Agreement-with-Kenya-Medical-Research-Institute-KEMRI-to-Design-Plan-and-Seek-Regulatory-Approval-for-a-Phase-I-Clinical-Study-of-TNX-801-f.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNXP","BK4583","CDC","BK4135","CNS","BK4139"],"gpt_icon":1},{"id":"2480470563","title":"Gilead : Jefferies Raises Target Price to $105 From $95","url":"https://stock-news.laohu8.com/highlight/detail?id=2480470563","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480470563?lang=en_us&edition=fundamental","pubTime":"2024-11-04 12:48","pubTimestamp":1730695683,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241104:nFWN3M81II:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BKVL7J92.USD","LU2087621335.USD","BK4583","BK4532","BK4566","LU0889565916.HKD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0109394709.USD","IE00B19Z3581.USD","LU1430594728.SGD","LU0320765992.SGD","LU1571399168.USD","IE00BSNM7G36.USD","LU2468319806.SGD","LU1066053197.SGD","BK4578","LU1066051498.USD","BK4588","BK4550","GILD","LU0289739699.SGD","LU1839511570.USD","LU0234570918.USD","LU0058720904.USD","BK4139","BK4568","IE00BZ1G4Q59.USD","BK4585","LU1585245621.USD"],"gpt_icon":0},{"id":"2480986824","title":"E-Home Announces Major Capital Reorganization Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2480986824","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480986824?lang=en_us&edition=fundamental","pubTime":"2024-11-02 04:57","pubTimestamp":1730494646,"startTime":"0","endTime":"0","summary":"E-Home Household Service Holdings (EJH) has released an update. E-Home Household Service Holdings is set to hold an extraordinary general meeting o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/e-home-announces-major-capital-reorganization-plans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/e-home-announces-major-capital-reorganization-plans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","BK4192","EJH","BK4211","BK4195","BK4539","HBCP"],"gpt_icon":0},{"id":"2480852068","title":"LiveOne Leads The Pack Of 3 US Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2480852068","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480852068?lang=en_us&edition=fundamental","pubTime":"2024-11-02 04:08","pubTimestamp":1730491696,"startTime":"0","endTime":"0","summary":"As the U.S. stock market navigates a landscape shaped by tech earnings and labor market data, investors are keenly observing how these factors influence broader economic conditions. Penny stocks, despite being an older term, continue to capture attention for their potential to offer growth opportunities at lower price points. When these smaller or newer companies exhibit strong financial health and promising fundamentals, they can present compelling opportunities for investors seeking value in less conventional areas of the market.Overview: Chimerix, Inc. is a biopharmaceutical company focused on developing medicines to improve and extend the lives of patients with deadly diseases, with a market cap of approximately $86.95 million.Operations: The company's revenue is derived entirely f","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Ff24jEG6fJ_mnhJ0xYBRaA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fbcb1fb47846c704491b7cdca16e4528","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Ff24jEG6fJ_mnhJ0xYBRaA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fbcb1fb47846c704491b7cdca16e4528"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liveone-leads-pack-3-us-200816707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4075","BK4505","CMRX","LYEL","BK4139","BABB","BK4209","ARC","BK4143","LVO","BK4563","BK4539","BK4583","BK4526","RLX","BK4551"],"gpt_icon":1}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction